The Latest Breaking News from Obesity

Traders sold the news on this biotech stock's conference update.

The discovery could lead to a new treatment for millions of people with obesity and type 2 diabetes who do not respond well to current treatments.

The popularity of weight loss drugs such as Ozempic and Mounjaro continue to reflect Americans’ desire to slim down. While these new drugs have offered a solution for people struggling with obesity, many eligible patients – especially Black adults – cannot afford the high price.

Researchers now suggest that vitamin D supplementation may be an effective, simple way to lower blood pressure levels in elderly adults with obesity.

Although metformin is prescribed during pregnancy to lower the risk of diabetes-related complications, such as obesity and diabetes in children, the study suggests that the drug itself may contribute to these same risks.

The drug semaglutide, commonly known by the brand names Ozempic or Wegovy, was originally developed to help people with type 2 diabetes manage their blood sugar levels.

Two-thirds of the UK population are either overweight or obese – a crisis that costs billions each year in healthcare and lost productivity. Yet, in a 2021 review of nearly 700 obesity-related policies in England, researchers at the University of Cambridge found no evidence they had successfully reduced obesity. A…

The world’s largest food and beverage companies are selling less healthy products in low-income countries compared to those in wealthier nations – contributing to the global obesity crisis as packaged foods become more prevalent worldwide, a report has warned.

“Aren’t they a little young for that?”

Women with polycystic ovary syndrome, also known as PCOS and obesity are more likely to have smaller babies in terms of birth weight, length, and head NTNU. Read further on Dynamite News:

Health and children’s groups urge UK ministers to impose levies on products containing too much salt or sugar